Institutional
AIHC Capital Management Ltd
CIK 0002103725
$119.7M
Reported AUM
5
Positions
Q1 2026
Period
2026-05-08
Filed
The Brief · AIHC Capital Management Ltd · Q1 2026
AI · grounded in 13F
AIHC Capital Management Ltd established a new position in ORIC valued at $31.16M. The fund closed its positions in PTGX, reducing exposure by $16.58M, and AVBP, reducing exposure by $12.97M. Additionally, the fund increased its stake in NBP by 446.63% while trimming shares of COGT by 48.60%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | $80.6M | 67.37% | -71,418 | -7.9% |
| 2 | ORIC | ORIC PHARMACEUTICALS INC | $31.2M | 26.04% | +2,459,551 | NEW |
| 3 | NBP | NOVABRIDGE BIOSCIENCES | $5.6M | 4.65% | +1,848,954 | +446.6% |
| 4 | COGT | COGENT BIOSCIENCES INC | $2.0M | 1.65% | -48,598 | -48.6% |
| 5 | KRRO | KORRO BIO INC | $343K | 0.29% | — | HELD |
| 6 | PTGX | PROTAGONIST THERAPEUTICS INC | — | — | -189,823 | EXITED |
| 7 | AVBP | ARRIVENT BIOPHARMA INC | — | — | -644,788 | EXITED |
Source: SEC EDGAR · accession 0001172661-26-001629. 13F discloses long positions only — shorts, foreign equities, and options are excluded.